• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

4LS:GR

2.001 EUR 0.116 6.15%

As of 13:53:38 ET on 04/17/2014.

Snapshot for Athersys Inc (4LS)

Open: 1.841 Day's Range: 1.841 - 2.001 Volume: 0
Previous Close: 1.885 52wk Range: 1.000 - 3.150 1-Yr Rtn: +22.99%

Stock Chart for 4LS

No chart data available.
  • 4LS:GR 2.001
  • 1D
  • 1M
  • 1Y
1.885
Interactive 4LS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4LS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3300
Est. PEG Ratio -
Market Cap (M EUR) 153.34
Shares Outstanding (M) 76.63
30 Day Average Volume 53
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4LS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4LS

Athersys Incorporated is a clinical-stage biotechnology company. The Company develops allogeneic stem cell products that focus on treating inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other conditions.

Gil Van BokkelenChairman/CEO/Co-FounderWilliam O Lehmann Jr "BJ"President/COO/Secretary
John J HarringtonExec VP/Chief Scientific OfcrRobert J DeansExec VP:Regenerative Medicine
More Company Profile & Key Executives for 4LS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil